Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ADUSNYSE:ARDTNASDAQ:PGNYNASDAQ:SHCR On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeADUSAddus HomeCare$118.00+1.2%$106.23$88.96▼$136.72$2.17B0.81169,294 shs159,635 shsARDTArdent Health Partners$13.37-2.3%$13.52$11.31▼$20.72$1.91BN/A386,341 shs423,049 shsPGNYProgyny$22.43+2.1%$22.00$13.39▼$30.42$1.92B1.321.71 million shs816,199 shsSHCRSharecare$1.43$1.43$0.48▼$1.44$531.79M0.512.55 million shsN/A5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceADUSAddus HomeCare+3.03%+4.82%+5.09%+23.07%+1.76%ARDTArdent Health Partners-8.35%-5.51%-5.87%-2.64%+1,362,999,900.00%PGNYProgyny+1.34%+1.24%+3.63%+10.13%-20.40%SHCRSharecare0.00%0.00%0.00%0.00%+70.66%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationADUSAddus HomeCare4.6462 of 5 stars2.63.00.05.03.02.52.5ARDTArdent Health Partners3.2784 of 5 stars3.50.00.00.02.40.03.1PGNYProgyny1.1536 of 5 stars1.22.00.00.03.51.71.3SHCRSharecareN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceADUSAddus HomeCare 3.25Buy$142.5720.82% UpsideARDTArdent Health Partners 3.00Buy$20.6754.57% UpsidePGNYProgyny 2.42Hold$23.454.57% UpsideSHCRSharecare 2.00Hold$1.43N/ACurrent Analyst Ratings BreakdownLatest SHCR, PGNY, ADUS, and ARDT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/10/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$133.005/20/2025ARDTArdent Health PartnersStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$21.00 ➝ $21.005/15/2025ARDTArdent Health PartnersRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$21.00 ➝ $21.005/12/2025PGNYProgynyCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$23.00 ➝ $21.005/9/2025ARDTArdent Health PartnersGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$16.00 ➝ $18.005/8/2025ADUSAddus HomeCareMacquarieSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$129.00 ➝ $133.004/22/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/10/2025ADUSAddus HomeCareJMP SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingMarket Outperform ➝ Market Outperform$150.00 ➝ $150.004/9/2025ARDTArdent Health PartnersGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$16.004/9/2025ARDTArdent Health PartnersMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$19.00 ➝ $18.004/1/2025ARDTArdent Health PartnersStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$22.00 ➝ $22.00(Data available from 6/10/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookADUSAddus HomeCare$1.21B1.79$5.45 per share21.65$43.58 per share2.71ARDTArdent Health Partners$6.02B0.32N/AN/AN/A∞PGNYProgyny$1.21B1.58$0.63 per share35.58$5.77 per share3.89SHCRSharecare$445.25M1.19N/AN/A$1.22 per share1.17Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateADUSAddus HomeCare$62.52M$4.4327.0022.011.416.50%9.62%7.37%8/4/2025 (Estimated)ARDTArdent Health Partners$53.90M$1.638.206.82N/AN/AN/AN/A8/13/2025 (Estimated)PGNYProgyny$62.04M$0.5738.6734.512.395.03%11.36%7.87%8/5/2025 (Estimated)SHCRSharecare-$128.50M-$0.39N/AN/AN/A-33.64%-22.81%-15.96%N/ALatest SHCR, PGNY, ADUS, and ARDT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025PGNYProgyny$0.45$0.17-$0.28$0.17$307.86 million$324.04 million5/6/2025Q1 2025ARDTArdent Health Partners$0.21$0.29+$0.08$0.29$1.50 billion$1.50 billion5/5/2025Q1 2025ADUSAddus HomeCare$1.33$1.42+$0.09$1.16$341.66 million$337.71 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthADUSAddus HomeCareN/AN/AN/AN/AN/AARDTArdent Health PartnersN/AN/AN/AN/AN/APGNYProgynyN/AN/AN/AN/AN/ASHCRSharecareN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioADUSAddus HomeCareN/A2.112.11ARDTArdent Health Partners0.781.911.78PGNYProgynyN/A2.622.62SHCRSharecareN/A2.022.02Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipADUSAddus HomeCare95.35%ARDTArdent Health PartnersN/APGNYProgyny94.93%SHCRSharecare35.08%Insider OwnershipCompanyInsider OwnershipADUSAddus HomeCare4.60%ARDTArdent Health Partners1.70%PGNYProgyny9.40%SHCRSharecare30.61%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableADUSAddus HomeCare33,20018.40 million17.30 millionOptionableARDTArdent Health Partners24,200143.04 millionN/AOptionablePGNYProgyny31085.72 million74.68 millionOptionableSHCRSharecare3,352371.88 million258.05 millionOptionableSHCR, PGNY, ADUS, and ARDT HeadlinesRecent News About These CompaniesBronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Stockholders to ConnectJune 10 at 10:00 AM | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Shareholders to Learn More About the InvestigationJune 8 at 10:00 AM | accessnewswire.comSharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationJune 5, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Shareholders to Inquire about Securities InvestigationJune 3, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Shareholders to ConnectJune 1, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Investors to ConnectMay 29, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Stockholders to Inquire about Securities InvestigationMay 27, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Investors to Learn More About the InvestigationMay 25, 2025 | accessnewswire.comSharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the InvestigationMay 22, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Investors to ConnectMay 20, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Stockholders to Learn More About the InvestigationMay 18, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Investors to Inquire about Securities InvestigationMay 15, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Investors to Reach OutMay 13, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Stockholders to Reach OutMay 11, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Stockholders to ConnectMay 8, 2025 | accessnewswire.comSharecare Inc. (SHCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the InvestigationMay 6, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Encourages Sharecare Inc. (SHCR) Shareholders to Inquire about Securities InvestigationMay 4, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Is Investigating Sharecare Inc. (SHCR) And Encourages Shareholders to ConnectMay 1, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sharecare Inc. (SHCR) And Encourages Shareholders to Reach OutApril 29, 2025 | accessnewswire.comBronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sharecare Inc. (SHCR) and Encourages Investors to Learn More About the InvestigationApril 24, 2025 | accessnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeSHCR, PGNY, ADUS, and ARDT Company DescriptionsAddus HomeCare NASDAQ:ADUS$118.00 +1.44 (+1.24%) Closing price 04:00 PM EasternExtended Trading$118.12 +0.13 (+0.11%) As of 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company's payor clients include federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.Ardent Health Partners NYSE:ARDT$13.37 -0.31 (-2.27%) Closing price 03:59 PM EasternExtended Trading$14.00 +0.63 (+4.70%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ardent Health Partners, Inc. owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee. Ardent Health Partners, Inc. is a subsidiary of EGI-AM Investments, L.L.C.Progyny NASDAQ:PGNY$22.43 +0.46 (+2.09%) Closing price 04:00 PM EasternExtended Trading$22.32 -0.11 (-0.51%) As of 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.Sharecare NASDAQ:SHCRSharecare, Inc. operates as a digital healthcare platform company. Its Sharecare platform connects people, patients, providers, employers, health plans, government organizations, and communities that optimize individual and population-wide well-being. The company offers enterprise solutions based on a software-as-a-service model that allows enterprise clients to message, motivate, and manage their populations, as well as measure their population progress; a suite of data and information-driven solutions; and life sciences solutions, which provides members with personalized information, programs, and resources to improve their health and well-being. It also operates RealAge, a platform for health assessment to assess behaviors and existing conditions of its members and provide metric for their physical health. In addition, the company provides secure, automated release of information, audit, and business consulting services to streamline the medical records process for medical facilities. It sells its solutions through direct sales organization and partner relationships. Sharecare, Inc. was founded in 2009 and is headquartered in Atlanta, Georgia. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas CrowdStrike Stock Hits All-Time Highs: Smart Buy or FOMO Trap? These 3 Stocks Could Be Back in Play Before You Know It Casey’s Surges on Strong Q4, More Gains Likely Ahead Qualcomm: What Monday’s Jump Tells Us About the Stock's Prospects Government Mandate Sends eVTOL Stocks Flying AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway Meta Pulls Ahead of the Mag 7: Analysts Predict a Breakout Year ASML’s AI Edge: How Its EUV Tech Is Creating a New Monopoly Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
